Astellas touts data from early test of stem cell-derived eye therapy
Astellas reported promising results with its stem cell-derived therapy in an age-related eye disease, though data in a handful of high-dose patients in the early-stage study raised questions. The experimental stem cell therapy, called ASP7317 ...
May 7, 2026 06:13 PM EDT R&D Astellas touts data from early test of stem cell-derived eye therapy Lei Lei Wu News Reporter Astellas reported promising results with its stem cell-derived therapy in an age-related eye disease, though data in a handful of high-dose patients in the early-stage … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that